New
New grant for research in vitiligo announced in Denver
We are pleased to announce that John E. Harris, M.D., Ph.D., a distinguished vitiligo investigator from University of Massachusetts, was awarded with a grant by Dermatology Foundation to continue research on Skin-Resident Memory T Cells in Vitiligo. Last year, VRF has supported John Harris' project that aims to test some new substances for vitiligo treatment using his unique mouse model of vitiligo. If successful, this could be a critical step towards developing a new approach to vitiligo treatment.
FAQOther Questions
- Is it possible to stop the progression of vitiligo?
While it's not always possible to quickly stop vitiligo progression, there are some treatments that can help slow or halt the spread of the condition in many cases: Corticostero...
- Safety of clinical trials. Can my child leave it for any reason?
Pediatric vitiligo trials · Safety and choice Who watches your child, what may need to pause and what happens if your family changes its mind. Two studies discussed here are eva...
- Can chemicals cause vitiligo?
Certain chemicals can trigger vitiligo, leading to a condition known as chemical-induced vitiligo. While clinically and histologically indistinguishable from other types of viti...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.